三博脑科（301293）公告，2024年营业收入14.29亿元，同比增长8.84%。归属于上市公司股东的净利润 1.05亿元，同比增长34.24%。基本每股收益0.51元/股，同比增长24.39%。公司拟向全体股东每10股派发 现金红利1.48元(含税)，送红股0股(含税)，以资本公积金向全体股东每10股转增0股。 ...

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Sanbo Neuroscience, which has a current stock price of 45.2 yuan and a rolling PE ratio of 84.92 times, significantly higher than the industry average of 46.29 times [1][2] - As of September 30, 2024, Sanbo Neuroscience has 27,403 shareholders, an increase of 2,446 from the previous period, with an average holding value of 352,800 yuan per shareholder [1] - The company specializes in clinical medical services in neurology, with a focus on complex surgeries, achieving a high volume of operations, particularly in advanced neurosurgery [1] Group 2 - In the latest financial report for Q3 2024, Sanbo Neuroscience reported a revenue of 1.059 billion yuan, representing a year-on-year increase of 9.83%, and a net profit of 105 million yuan, up 42.93% year-on-year, with a gross margin of 24.97% [1] - The company ranks 37th in terms of PE ratio within the medical services industry, which has an average PE of 46.29 times and a median of 47.83 times [2]

证券代码：301293 证券简称：三博脑科 公告编号：2025-007 三博脑科医院管理集团股份有限公司 关于股份回购进展情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 三博脑科医院管理集团股份有限公司（以下简称"公司"）于 2024 年 4 月 17 日召开第三届董事会第四次会议，审议通过了《关于回购公司股份方案的议案》， 拟使用不低于 8,000 万元（含本数）且不超过 16,000 万元（含本数）的自有资金 以集中竞价交易方式回购公司已发行的人民币普通股（A 股），并在未来适宜时 机将回购股份用于股权激励或员工持股计划。因公司实施 2023 年年度权益分派 方案，公司对本次回购价格上限进行了调整，由 90 元/股调整为 69.16 元/股。在 回购价格不超过 69.16 元/股（含本数）的条件下，按照本次回购资金总额上限测 算，回购数量约为 2,313,475 股，约占公司总股本的 1.12%；按照本次回购资金 总额下限测算，回购数量约为 1,156,737 股，约占公司总股本的 0.56%。本次回 购实施期限自董事会审议通过本次回购股份方案 ...

股东方面，截至2024年9月30日，三博脑科股东户数27403户，较上次增加2446户，户均持股市值35.28 万元，户均持股数量2.76万股。 三博脑科医院管理集团股份有限公司的主要业务是临床医疗服务的神经专科医疗，主要诊疗类型包含神 经外科、神经介入、神经内科、神经肿瘤化疗、神经肿瘤放疗、神经重症等。三博脑科以神经医学专家 栾国明、于春江、石祥恩、王保国、闫长祥、吴斌、周健、张宏伟等教授为核心，聚集了一大批具有渊 博医学知识、丰富临床经验和现代医学理念的医疗精英。在这些专家学者的带领下，三博脑科累计完成 神经外科手术量居全国前列，且80%为难度最大的四级手术，技术实力全国领先。 最新一期业绩显示，2024年三季报，公司实现营业收入10.59亿元，同比9.83%；净利润1.05亿元，同比 42.93%，销售毛利率24.97%。 4月1日，三博脑科今日收盘49.29元，上涨1.59%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到92.60倍，总市值101.53亿元。 从行业市盈率排名来看，公司所处的医疗服务行业市盈率平均52.86倍，行业中值49.90倍，三博脑科排 名第37位。 序号股票简称 ...

Key Points - The article emphasizes the Chinese government's commitment to implementing proactive macro policies to support economic stability and growth, including potential new policies if necessary [2] - The article highlights the importance of enhancing the business environment for various enterprises through economic reforms and addressing bottlenecks in economic circulation [2] - The article discusses the upcoming significant events in the global market, including earnings reports from major companies and important economic data releases [4] Macro - Premier Li Qiang met with U.S. senators, stating that trade wars yield no winners and emphasizing the need for cooperation to address trade imbalances [6] - Vice Premier He Lifeng welcomed multinational companies to invest in China, highlighting the resilience and potential of the Chinese economy [6] - The government plans to deepen supply-side structural reforms and regulate competition to promote high-quality development [6] Domestic Stock Market - CITIC Securities identified two critical time points for the market: the first in early April when external risks are expected to materialize, and the second mid-year when U.S. economic and policy cycles may align with China's [9] - The "Leading Enterprise" action plan in Guangzhou aims to enhance the integration of industry and capital, promoting more competitive companies to go public [9] - The report notes a significant increase in new account openings at several securities firms, indicating growing market participation [10] Financial - A surge in the number of funds focusing on free cash flow indicates a market trend towards financial health metrics, driven by demand and policy direction [14] - The head of the Industrial and Commercial Bank of China emphasized the shift from a capital-centric to a technology-centric financial service model [14] Real Estate - Suggestions were made to stabilize asset prices and improve income levels to boost consumer spending, particularly in real estate and equity markets [17] Industry - XPeng Motors' chairman discussed the future of high-level autonomous driving technology, predicting significant advancements in the coming years [19] - The Henan province announced plans for extensive 5G infrastructure development, aiming for over 270,000 5G base stations in the next three years [19] Overseas - The WTO Director-General highlighted the U.S. as a major beneficiary of global trade, countering claims of trade disadvantages [21] - The UK government plans to invest £600 million to address skill shortages in the construction sector, crucial for housing development [22] International Stock Market - SpaceX aims to achieve a weekly launch frequency for its Starship within a year, enhancing its operational capabilities [23] Commodity - The China Iron and Steel Association noted that supply-demand imbalances are a key issue in the industry, advocating for the closure of new production capacity [26] - Methanol port inventories have decreased, indicating a market shift towards destocking [26] - BHP's CEO projected a significant copper supply gap in the next decade, emphasizing the need for substantial investment in mining [26] Bonds - The government plans to issue long-term special bonds to support various initiatives, with a focus on local government debt management [28] - The AI and robotics sectors are identified as key drivers of market growth, with expectations for increased investment opportunities [28]

人民财讯3月23日电，三博脑科(301293)3月23日晚间公告，持有公司股份15.93%的股东TBP 3Doctors (HK) Limited（以下简称"TBP"）计划以集中竞价方式减持本公司股份不超过113.21万股（占剔除公司回 购专用账户股份数量后总股本的0.56%）。 ...

证券代码：301293 证券简称：三博脑科 公告编号：2025-006 三博脑科医院管理集团股份有限公司 关于持股 5%以上股东减持股份的预披露公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 持有三博脑科医院管理集团股份有限公司（以下简称"公司"）股份 32,330,025 股（占剔除公司回购专用账户股份数量后总股本的 15.93%）的持股 5%以上股东 TBP 3Doctors (HK) Limited（以下简称"TBP"）计划在本公告披露之日起十五个 交易日后的三个月内以集中竞价方式减持本公司股份不超过 1,132,075 股（占剔 除公司回购专用账户股份数量后总股本的 0.56%）。 一、股东减持公司股份计划 公司收到股东 TBP 出具的《关于股份减持计划的告知函》，现将相关情况 公告如下： 1、计划减持股东的情况 截至本公告披露日，本次拟减持的股东持有公司股份情况如下： | | 股东名称 | | 持股数量（股） | 占剔除公司回购专用账户 | | --- | --- | --- | --- | --- | | | | | | 股份数量 ...

Investment Rating - The report maintains a "Positive" investment rating for the brain-computer interface (BCI) industry [1]. Core Insights - The BCI technology has significant potential in the healthcare sector, particularly for improving the quality of life for patients with severe motor disabilities and other neurological disorders [4]. - The global BCI market is experiencing rapid growth, with a compound annual growth rate (CAGR) of 11.85% from 2018 to 2023, projected to reach $10.8 billion by 2033, with a CAGR of 16.48% from 2023 to 2033 [4][25]. - The Chinese BCI market is also expanding quickly, expected to reach 5.58 billion yuan by 2027, with a CAGR of 20.29% [4]. - The healthcare sector accounted for 46.14% of the BCI market share in 2024, with potential market sizes in serious medical applications estimated between $15 billion and $85 billion by 2030-2040 [4][32]. Summary by Sections 1. Introduction to Brain-Computer Interfaces - BCI technology interprets brain signals to control external devices, significantly benefiting patients with severe motor disabilities [11]. - The development of BCI technology has gained global attention, with various projects moving from laboratory settings to practical applications [11]. 2. Investment Landscape of Brain-Computer Interfaces - The global BCI market size grew from $1.2 billion in 2018 to $2.35 billion in 2023, with non-invasive BCI being the primary research focus [25]. - Major countries are supporting BCI technology through various initiatives, including the U.S. "Brain Research Initiative" and the EU's "Human Brain Project" [28]. 3. Key Technologies and Current Development Status - BCI systems are categorized into input and output types, with various signal acquisition methods including invasive, semi-invasive, and non-invasive techniques [20][24]. - The report highlights the challenges faced by BCI technology, including complex EEG signals and limitations in decoding accuracy [4]. 4. Company Analysis in the BCI Sector - Notable companies in the BCI field include Cheng Yi Tong, Xiang Yu Medical, and Sanbo Neuroscience, which are recognized for their advancements in BCI technology [4].

三博脑科医院管理集团股份有限公司 反舞弊与举报制度 第一章 总则 1 目的 为加强三博脑科医院管理集团股份有限公司（以下简称"公司"）的内部控制，规范公司员工 行为，降低公司经营风险，维护公司和股东合法权益，确保公司经营目标的实现和公司持续稳 定发展，根据《中华人民共和国证券法》《深圳证券交易所上市公司自律监管指引第 2 号—— 创业板上市公司规范运作》《企业内部控制基本规范》《中华人民共和国公司法》《中华人民 共和国审计法》等法律、行政法规、部门规章、规范性文件的要求，结合公司实际情况，制定 本制度。 反舞弊工作的宗旨是规范公司全体员工的职业行为，严格遵守相关法律法规、行业规范、职业 道德及公司的规章制度，树立廉洁和勤勉敬业的良好风气，防止损害公司及股东的利益的行为 发生。 2 适用范围 本制度适用于三博脑科医院管理集团股份有限公司及分子公司。 3 定义 5.1 管理层负责建立健全包括预防舞弊在内的内部控制机制； 5.2 管理层负责实施控制措施以降低舞弊发生的机会，对舞弊行为采取适当且有效的补救措施， 并进行自我评估。 6 审计部 1 6.1 审计部是公司反舞弊的责任部门； 3.1 本制度所称舞弊是指公司内 ...

证券代码：301293 证券简称：三博脑科 公告编号：2025-004 三博脑科医院管理集团股份有限公司 第三届董事会第十一次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 三博脑科医院管理集团股份有限公司（以下简称"公司"）第三届董事会第十 一次会议于 2025 年 3 月 4 日在公司会议室以现场结合通讯的方式召开。会议通 知于 2025 年 2 月 25 日以电子邮件等方式发出。本次会议应出席董事 9 名，实际 出席的董事 9 人，会议由董事长张阳先生主持，公司监事、高级管理人员列席了 会议。本次会议的召集、召开和表决程序符合《公司法》等法律、法规和《公司 章程》的有关规定。 二、董事会会议审议情况 经与会董事认真审议，会议形成了如下决议： （一）审议通过《关于变更总经理的议案》 表决结果：9 票同意，0 票反对，0 票弃权。 1 《舆情管理制度》详见巨潮资讯网（www.cninfo.com.cn）。 （三）审议通过《关于制定<反舞弊与举报制度>的议案》 表决结果：9 票同意，0 票反对，0 票弃权。 根据公司经营发 ...